heme-onc-consultant

Provide tiered hematology/oncology guidance with PubMed evidence and tumor board simulation.

2|1|Updated Nov 7, 2025
Search Tags:#diagnosis
One-click install
npx skills add https://github.com/ericbuess/claude-skills --skill heme-onc-consultant
Or copy as Structured Prompt for Agent
Please help me install this Agent Skill.
Skill: heme-onc-consultant
Source: https://github.com/ericbuess/claude-skills/tree/main/heme-onc-consultant
Command: npx skills add https://github.com/ericbuess/claude-skills --skill heme-onc-consultant

SYSTEM DOCUMENTATION & REQUIREMENTS

💡 This Skill includes scripts (resource) and references (resource) components.

What problem does it solve?

Clinicians face complex hematology/oncology cases requiring rapid, evidence-based decisions under pressure. This Skill automates the process of getting immediate guidance, followed by deep, multi-specialty analysis, reducing diagnostic dilemmas and treatment planning uncertainty.

Core Features & Use Cases

  • Tiered Decision Support: Get immediate clinical guidance (Tier 1) or request a comprehensive multi-agent analysis simulating a tumor board (Tier 2).
  • Adversarial Validation: Automatically challenges initial diagnoses and treatment plans to identify weaknesses and explore alternatives, ensuring robust recommendations.
  • Evidence-Based Research: Leverages PubMed tools for real-time literature review, citing Level I evidence and current guidelines (NCCN, ASCO, ASH, EHA).
  • Use Case: A physician has a patient with new pancytopenia and circulating blasts. They can use this Skill for immediate guidance on acute leukemia workup (Tier 1). For a complex relapsed AML case, they can request a "full tumor board analysis" for deep multi-agent reasoning, risk-benefit quantification, and evidence synthesis (Tier 2).

Quick Start

Use the heme-onc-consultant skill to provide rapid guidance for a 67-year-old male with new pancytopenia, WBC 2.1, Hgb 8.4, Plt 45, and circulating blasts. What are the next steps?

Frequently Asked Questions about heme-onc-consultant

High-intent search queries and answers about installing and using this skill.

FAQPage Schema
How do I get rapid evidence-based guidance for hematology and oncology diagnostic cases?

Rapid hematology/oncology diagnostic guidance delivers immediate, evidence-based clinical recommendations for urgent cases. This Skill provides Tier 1 fast responses citing current guidelines (NCCN, ASCO, ASH, EHA) and Level I evidence from PubMed, reducing diagnostic uncertainty under time pressure.

Can I request deep multi-specialty analysis for complex hematology/oncology cases beyond initial guidance?

Yes. Tier 2 deep analysis simulates a multi-agent tumor board, applying adversarial validation to challenge diagnoses and treatment plans. This identifies weaknesses, explores alternatives, and synthesizes structured evidence for complex cases like relapsed AML.

How does adversarial validation improve hematology/oncology treatment planning?

Adversarial validation automatically challenges initial diagnoses and recommendations to expose blind spots and alternatives. For treatment planning, it quantifies risk-benefit trade-offs and strengthens robustness before clinical implementation.

What's the workflow for workup of pancytopenia with circulating blasts using rapid decision support?

Submit patient labs (WBC, hemoglobin, platelet count, blast percentage) for immediate guidance on acute leukemia workup pathways. The Skill returns prioritized diagnostic steps and evidence citations, with optional Tier 2 tumor board analysis for complex presentations.

Does this support evidence synthesis from current medical literature for hematology/oncology cases?

Yes. PubMed access enables real-time literature review, extracting Level I evidence and current guideline citations (NCCN, ASCO, ASH, EHA) for diagnosis and treatment recommendations within clinical guidance.

When should I request full tumor board simulation versus immediate Tier 1 guidance?

Use Tier 1 for urgent decisions requiring fast answers. Request Tier 2 tumor board simulation for complex, high-stakes cases—relapsed malignancies, rare diagnoses, or multi-system involvement—where multi-specialty reasoning and evidence synthesis justify deeper analysis.